Inflammatory mediators and islet ?-cell failure: a link between type 1 and type 2 diabetes
Open accessThe DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.
Abstract
Pancreatic islet beta-cell death occurs in type 1 and 2 diabetes mellitus, leading to absolute or relative insulin deficiency. beta-cell death in type 1 diabetes is due predominantly to autoimmunity. In type 2 diabetes beta-cell death occurs as the combined consequence of increased circulating glucose and saturated fatty acids together with adipocyte secreted factors and chronic activation of the innate immune system. In both diabetes types intra-islet inflammatory mediators seem to trigger a final common pathway leading to beta-cell apoptosis. Therefore anti-inflammatory therapeutic approaches designed to block beta-cell apoptosis could be a significant new development in type 1 and 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Direct effects of inflammation on β-cells arise from activation of the intra-islet immune response, the strongest support being for a role for interleukin-1β (IL-1β)71.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [71]
In the citing paper
“In fact, the chronic activation of the innate immune system, leading to intra-islet inflammation also seems to be the key part of β cells apoptosis (77).”
From Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments (2020) · cites this paper as [77]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Nagata, S. (1997) · Cell · doi:10.1016/s0092-8674(00)81874-7 · Cited by 4,938
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543 · cited 1×
“However, it is unclear whether adipose tissue releases sufficient amounts of TNFα into the circulation [53].”
BackgroundA central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359 · cited 1×
“Recently it was demonstrated that JNK activity is abnormally elevated in liver, fat, and muscle in dietary and genetic mouse models of obesity [134].”
BackgroundYuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884 · cited 1×
“It is likely that part of those observations are related to changes in insulin resistance and not only in β-cell function [157, 158].”
BackgroundInhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,753
The Instructive Role of Innate Immunity in the Acquired Immune Response
Fearon, D. T., & Locksley, R. M. (1996) · Science · doi:10.1126/science.272.5258.50 · Cited by 1,719
Ridker, P. M., Rifai, N., Clearfield, M., Downs, J. R., Weis, S. E., Miles, J. S., & Gotto, A. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106283442601 · Cited by 1,557
Fried, S. K., Bunkin, D. A., & Greenberg, A. S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4660 · Cited by 1,528
Inflammatory Cytokines and the Risk to Develop Type 2 Diabetes
Spranger, J., Kroke, A., Möhlig, M., Hoffmann, K., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. H. (2003) · Diabetes · doi:10.2337/diabetes.52.3.812 · Cited by 1,493
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
Atkinson, M. A., & Eisenbarth, G. S. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05415-0 · Cited by 1,491
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2003) · Diabetes · doi:10.2337/diabetes.52.1.1 · Cited by 1,482
Pathologic anatomy of the pancreas in juvenile diabetes mellitus
Gepts, W. (1965) · Diabetes · doi:10.2337/diab.14.10.619 · Cited by 1,345 · cited 1×
“, mononuclear cell infiltration into the islets and selective β-cell destruction (insulitis) [3].”
BackgroundPickup, J. C., Mattock, M. B., Chusney, G. D., & Burt, D. (1997) · Diabetologia · doi:10.1007/s001250050822 · Cited by 1,242
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
Herold, K. C., Hagopian, W., Auger, J. A., Poumian-Ruiz, E., Taylor, L., Donaldson, D., Gitelman, S. E., Harlan, D. M., Xu, D., Zivin, R. A., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012864 · Cited by 1,222
Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J.-I., Cao, Z., & Matsumoto, K. (1999) · Nature · doi:10.1038/18465 · Cited by 1,182
Fried, S. K. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.3.847 · Cited by 1,145
Fatty acid-induced β cell apoptosis: A link between obesity and diabetes
Shimabukuro, M., Zhou, Y.-T., Levi, M., & Unger, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2498 · Cited by 1,142
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1995) · Nature · doi:10.1038/374479a0 · Cited by 1,126
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92172 · Cited by 1,114
Self-citationLipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications
Unger, R. H. (1995) · Diabetes · doi:10.2337/diab.44.8.863 · Cited by 1,100
Is Type II diabetes mellitus a disease of the innate immune system?
Pickup, J. C., & Crook, M. A. (1998) · Diabetologia · doi:10.1007/s001250051058 · Cited by 1,041
Diabetes in identical twins: A study of 200 pairs
Barnett, A. H., Eff, C., Leslie, R. D. G., & Pyke, D. A. (1981) · Diabetologia · doi:10.1007/bf00262007 · Cited by 959
A choice of death - the signal-transduction of immune-mediated beta-cell apoptosis
Eizirik, D. L., & Mandrup-Poulsen, T. (2001) · Diabetologia · doi:10.1007/s001250100021 · Cited by 888
Self-citationβ-Cell death during progression to diabetes
Mathis, D., Vence, L., & Benoist, C. (2001) · Nature · doi:10.1038/414792a · Cited by 884
Effects of insulin in relatives of patients with type 1 diabetes mellitus
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012350 · Cited by 836
Hunt, J. V., Dean, R. T., & Wolff, S. P. (1988) · Biochemical Journal · doi:10.1042/bj2560205 · Cited by 777
Ridker, P. M., Rifai, N., & Clearfield, M. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00460-3 · Cited by 760
Prevention of fat-induced insulin resistance by salicylate
Kim, J. K., Kim, Y.-J., Fillmore, J. J., Chen, Y., Moore, I., Lee, J., Yuan, M., Li, Z. W., Karin, M., Perret, P., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11559 · Cited by 737
Dunne, A., & O'Neill, L. A. J. (2003) · Science's STKE · doi:10.1126/stke.2003.171.re3 · Cited by 711
Sakuraba, H., Mizukami, H., Yagihashi, N., Wada, R., Hanyu, C., & Yagihashi, S. (2002) · Diabetologia · doi:10.1007/s125-002-8248-z · Cited by 681
The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes
Wilkin, T. J. (2001) · Diabetologia · doi:10.1007/s001250100548 · Cited by 623 · cited 3×
“This reflects a difference in the rapidity of β-cell destruction but not in the hallmark of the diseases: β-cell apoptosis [21].”
BackgroundDynamics of β-cell Mass in the Growing Rat Pancreas: Estimation With a Simple Mathematical Model
Finegood, D. T., Scaglia, L., & Bonner-Weir, S. (1995) · Diabetes · doi:10.2337/diab.44.3.249 · Cited by 603
Oyadomari, S., Takeda, K., Takiguchi, M., Gotoh, T., Matsumoto, M., Wada, I., Akira, S., Araki, E., & Mori, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191207498 · Cited by 599
TAB1: An Activator of the TAK1 MAPKKK in TGF-β Signal Transduction
Shibuya, H., Yamaguchi, K., Shirakabe, K., Tonegawa, A., Gotoh, Y., Ueno, N., Irie, K., Nishida, E., & Matsumoto, K. (1996) · Science · doi:10.1126/science.272.5265.1179 · Cited by 587
Tuomi, T., Groop, L. C., Zimmet, P. Z., Rowley, M. J., Knowles, W., & Mackay, I. R. (1993) · Diabetes · doi:10.2337/diab.42.2.359 · Cited by 581
Islet Pathology and the Pathogenesis of Type 1 and Type 2 Diabetes mellitus Revisited
Klöppel, G., Löhr, M., Habich, K., Oberholzer, M., & Heitz, P. U. (1985) · Pathology and Immunopathology Research · doi:10.1159/000156969 · Cited by 577
Cell-Permeable Peptide Inhibitors of JNK
Bonny, C., Oberson, A., Negri, S., Sauser, C., & Schorderet, D. F. (2001) · Diabetes · doi:10.2337/diabetes.50.1.77 · Cited by 571
Distinct Effects of Saturated and Monounsaturated Fatty Acids on β-Cell Turnover and Function
Maedler, K., Spinas, G. A., Dyntar, D., Moritz, W., Kaiser, N., & Donath, M. Y. (2001) · Diabetes · doi:10.2337/diabetes.50.1.69 · Cited by 552
Self-citationThe caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways
Kataoka, T., Budd, R. C., Holler, N., Thome, M., Martinon, F., Irmler, M., Burns, K., Hahne, M., Kennedy, N., Kovacsovics, M., et al. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00512-1 · Cited by 552
Fatty acids, lipotoxicity and insulin secretion
McGarry, J. D., & Dobbins, R. L. (1999) · Diabetologia · doi:10.1007/s001250051130 · Cited by 552
The Diabetes Control and Complications Trial Research Group (1994) · Retina · doi:10.1097/00006982-199414030-00022 · Cited by 551
Maedler, K., Oberholzer, J., Bucher, P., Spinas, G. A., & Donath, M. Y. (2003) · Diabetes · doi:10.2337/diabetes.52.3.726 · Cited by 549
Self-citationThe role of interleukin-1 in the pathogenesis of IDDM
Mandrup-Poulsen, T. (1996) · Diabetologia · doi:10.1007/bf00400649 · Cited by 543
Self-citationClark, A., Wells, C. A., BULEY, I. D., Cruickshank, J. K., Vanhegan, R. I., Matthews, D. R., Cooper, G. J. S., Holman, R. R., & Turner, R. C. (1988) · PubMed · Cited by 518
Endoplasmic reticulum stress-mediated apoptosis in pancreatic β-cells
Oyadomari, S., Araki, E., & Mori, M. (2002) · Apoptosis · doi:10.1023/a:1016175429877 · Cited by 517
Newton, K. (1998) · The EMBO Journal · doi:10.1093/emboj/17.3.706 · Cited by 499
TNF-Induced Signaling in Apoptosis
Rath, P. C., & Aggarwal, B. B. (1999) · Journal of Clinical Immunology · doi:10.1023/a:1020546615229 · Cited by 462
Feutren, G., Assan, R., Karsenty, G., Du Rostu, H., Sirmai, J., Papoz, L., Vialettes, B., Vexiau, P., Rodier, M., Lallemand, A., et al. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91943-4 · Cited by 448
Zimmet, P., Tuomi, T., Mackay, I. R., Rowley, M. J., Knowles, W., Cohen, M., & Lang, D. A. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00275.x · Cited by 413
Donath, M. Y., Gross, D. J., Cerasi, E., & Kaiser, N. (1999) · Diabetes · doi:10.2337/diabetes.48.4.738 · Cited by 405
Self-citationDiabetes risk score: towards earlier detection of Type 2 diabetes in general practice
Griffin, S. J., Little, P. S., Hales, C. N., Kinmonth, A. L., & Wareham, N. J. (2000) · Diabetes/Metabolism Research and Reviews · doi:10.1002/1520-7560(200005/06)16:3<164::aid-dmrr103>3.0.co;2-r · Cited by 402
Glucose Induces β-Cell Apoptosis Via Upregulation of the Fas Receptor in Human Islets
Maedler, K., Spinas, G. A., Lehmann, R., Sergeev, P., Weber, M., Fontana, A., Kaiser, N., & Donath, M. Y. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1683 · Cited by 367
Self-citationGlucose and Tolbutamide Induce Apoptosis in Pancreatic β-Cells
Efanova, I. B., Zaitsev, S. V., Zhivotovsky, B., Köhler, M., Efendić, S., Orrenius, S., & Berggren, P.-O. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.50.33501 · Cited by 364
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller‐Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15318 · Cited by 363
Self-citationMatsuoka, T., Kajimoto, Y., Watada, H., Kaneto, H., Kishimoto, M., Umayahara, Y., Fujitani, Y., Kamada, T., Kawamori, R., & Yamasaki, Y. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119126 · Cited by 359
The pancreatic islets in diabetes
Gepts, W., & Lecompte, P. M. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90417-4 · Cited by 349
Kaneto, H., Xu, G., Fujii, N., Kim, S., Bonner-Weir, S., & Weir, G. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202066200 · Cited by 349
ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway
Kopp, E., Medzhitov, R., Carothers, J., Xiao, C., Douglas, I., Janeway, C. A., & Ghosh, S. (1999) · Genes & Development · doi:10.1101/gad.13.16.2059 · Cited by 334
High Glucose Causes Apoptosis in Cultured Human Pancreatic Islets of Langerhans
Federici, M., Hribal, M., Perego, L., Ranalli, M., Caradonna, Z., Perego, C., Usellini, L., Nano, R., Bonini, P., Bertuzzi, F., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1290 · Cited by 333
Islet growth and development in the adult
Bonner-Weir, S. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0240297 · Cited by 331
de Vries, J. E., Vork, M. M., Roemen, T. H., de Jong, Y. F., Cleutjens, J. P., van der Vusse, G. J., & van Bilsen, M. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37421-6 · Cited by 324 · cited 1×
“Thus, saturated FFA are highly toxic whereas unsaturated FFA may prevent these deleterious effects [82, 83, 84, 85, 86].”
BackgroundEizirik, D. L., Flodström, M., Karlsen, A. E., & Welsh, N. (1996) · Diabetologia · doi:10.1007/bf00403906 · Cited by 319
Cytokines suppress human islet function irrespective of their effects on nitric oxide generation.
Eizirik, D. L., Sandler, S., Welsh, N., Cetkovic-Cvrlje, M., Nieman, A., Geller, D. A., Pipeleers, D. G., Bendtzen, K., & Hellerström, C. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117188 · Cited by 317
Shah, S. C., Malone, J., & Simpson, N. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903023200902 · Cited by 317
Müller, S., Martin, S., Koenig, W., Hanifi-Moghaddam, P., Rathmann, W., Haastert, B., Giani, G., Illig, T., Thorand, B., & Kolb, H. (2002) · Diabetologia · doi:10.1007/s00125-002-0829-2 · Cited by 311
Mandrup-Poulsen, T., Bendtzen, K., Dinarello, C. A., & Nerup, J. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.12.4077 · Cited by 304
Self-citationCardozo, A. K., Heimberg, H., Heremans, Y., Leeman, R., Kutlu, B., Kruhøffer, M., Ørntoft, T., & Eizirik, D. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108658200 · Cited by 301
Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations.
Byrne, M. M., Sturis, J., Clément, K., Vionnet, N., Pueyo, M. E., Stoffel, M., Takeda, J., Passa, P., Cohen, D., & Bell, G. I. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117064 · Cited by 300
Pukel, C., Baquerizo, H., & Rabinovitch, A. (1988) · Diabetes · doi:10.2337/diab.37.1.133 · Cited by 290
Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes?
Trudeau, J. D., Dutz, J. P., Arany, E., Hill, D. J., Fieldus, W. E., & Finegood, D. T. (2000) · Diabetes · doi:10.2337/diabetes.49.1.1 · Cited by 290
Insulin Resistance or Insulin Deficiency: Which Is the Primary Cause of NIDDM?
Taylor, S. I., Accili, D., & Imai, Y. (1994) · Diabetes · doi:10.2337/diab.43.6.735 · Cited by 289
Biologic functions of the IFN‐γ receptors
Tau, G., & Rothman, P. (1999) · Allergy · doi:10.1034/j.1398-9995.1999.00099.x · Cited by 288
Meier, C. A., Bobbioni, E., Gabay, C., Assimacopoulos-Jeannet, F., Golay, A., & Dayer, J.-M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8351 · Cited by 287
Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications
Unger, R. H. (1995) · Diabetes · doi:10.2337/diabetes.44.8.863 · Cited by 283
Hoorens, A., Van de Casteele, M., Klöppel, G., & Pipeleers, D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118950 · Cited by 277
THE GLUCOSE FATTY ACID CYCLE IN OBESITY AND MATURITY ONSET DIABETES MELLITUS
Randle, P. J., Garland, P. B., Newsholmet, E. A., & Hales, C. N. (1965) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb34800.x · Cited by 267
Processing of engulfed apoptotic bodies yields T cell epitopes
Bellone, M., Iezzi, G., Rovere, P., Galati, G., Ronchetti, A., Protti, M. P., Davoust, J., Rugarli, C., & Manfredi, A. A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.11.5391 · Cited by 261
Byrne, M. M., Sturis, J., Menzel, S., Yamagata, K., Fajans, S. S., Dronsfield, M. J., Bain, S. C., Hattersley, A. T., Velho, G., Froguel, P., et al. (1996) · Diabetes · doi:10.2337/diab.45.11.1503 · Cited by 259
Heimberg, H., Heremans, Y., Jobin, C., Leemans, R., Cardozo, A. K., Darville, M., & Eizirik, D. L. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2219 · Cited by 256
Development of Type 1 Diabetes despite Severe Hereditary B-Cell Deficiency
Martin, S., Wolf-Eichbaum, D., Duinkerken, G., Scherbaum, W. A., Kolb, H., Noordzij, J. G., & Roep, B. O. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010465 · Cited by 254
beta-cell apoptosis: stimuli and signaling.
Mandrup-Poulsen, T. (2001) · Diabetes · doi:10.2337/diabetes.50.2007.s58 · Cited by 253
Self-citationKANETO, H., FUJII, J., MYINT, T., MIYAZAWA, N., ISLAM, K. N., KAWASAKI, Y., SUZUKI, K., NAKAMURA, M., TATSUMI, H., YAMASAKI, Y., et al. (1996) · Biochemical Journal · doi:10.1042/bj3200855 · Cited by 252
Hardy, S., Langelier, Y., & Prentki, M. (2000) · PubMed · Cited by 248
LeRoith, D. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01276-7 · Cited by 236
Stassi, G., Maria, R. D., Trucco, G., Rudert, W., Testi, R., Galluzzo, A., Giordano, C., & Trucco, M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1193 · Cited by 235
Cardozo, A. K., Kruhøffer, M., Leeman, R., Ørntoft, T., & Eizirik, D. L. (2001) · Diabetes · doi:10.2337/diabetes.50.5.909 · Cited by 229
Ammendrup, A., Maillard, A., Nielsen, K., Aabenhus Andersen, N., Serup, P., Dragsbaek Madsen, O., Mandrup-Poulsen, T., & Bonny, C. (2000) · Diabetes · doi:10.2337/diabetes.49.9.1468 · Cited by 212
Self-citationProtection against lipoapoptosis of β cells through leptin-dependent maintenance of Bcl-2 expression
Shimabukuro, M., Wang, M.-Y., Zhou, Y.-T., Newgard, C. B., & Unger, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9558 · Cited by 212
Giannoukakis, N., Rudert, W. A., Trucco, M., & Robbins, P. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005943200 · Cited by 207
Laybutt, D. R., Kaneto, H., Hasenkamp, W., Grey, S., Jonas, J.-C., Sgroi, D. C., Groff, A., Ferran, C., Bonner-Weir, S., Sharma, A., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.2.413 · Cited by 202
Autoimmune islet destruction in spontaneous type 1 diabetes is not β-cell exclusive
Winer, S., Tsui, H., Lau, A., Song, A., Li, X., Cheung, R. K., Sampson, A., Afifiyan, F., Elford, A., Jackowski, G., et al. (2003) · Nature Medicine · doi:10.1038/nm818 · Cited by 200
Dyntar, D., Eppenberger-Eberhardt, M., Maedler, K., Pruschy, M., Eppenberger, H. M., Spinas, G. A., & Donath, M. Y. (2001) · Diabetes · doi:10.2337/diabetes.50.9.2105 · Cited by 194
Self-citationβ-Adrenergic Regulation of IL-6 Release from Adipose Tissue:In Vivo and in Vitro Studies
Mohamed-Ali, V., Flower, L., Sethi, J., Hotamisligil, G., Gray, R., Humphries, S. E., York, D. A., & Pinkney, J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8104 · Cited by 190
Increased Activity of L-Type Ca 2+ Channels Exposed to Serum from Patients with Type I Diabetes
Juntti-Berggren, L., Larsson, O., Rorsman, P., Ämmälä, C., Bokvist, K., Wåhlander, K., Nicotera, P., Dypbukt, J., Orrenius, S., Hallberg, A., et al. (1993) · Science · doi:10.1126/science.7686306 · Cited by 187
Mouse islet cell lysis mediated by interleukin-1-induced Fas
Yamada, K., Takane-Gyotoku, N., Yuan, X., Ichikawa, F., Inada, C., & Nonaka, K. (1996) · Diabetologia · doi:10.1007/s001250050574 · Cited by 183
DiLorenzo, T. P., Graser, R. T., Ono, T., Christianson, G. J., Chapman, H. D., Roopenian, D. C., Nathenson, S. G., & Serreze, D. V. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12538 · Cited by 181
Increased levels of acute-phase serum proteins in diabetes
McMillan, D. E. (1989) · Metabolism · doi:10.1016/0026-0495(89)90038-3 · Cited by 175
Cytotoxic Effects of Cytokines on Human Pancreatic Islet Cells in Monolayer Culture*
RABINOVITCH, A., SUMOSKI, W., RAJOTTE, R. V., & WARNOCK, G. L. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-1-152 · Cited by 170
Antibodies to Glutamic Acid Decarboxylase Discriminate Major Types of Diabetes Mellitus
Rowley, M. J., Mackay, I. R., Chen, Q.-Y., Knowles, W. J., & Zimmet, P. Z. (1992) · Diabetes · doi:10.2337/diab.41.4.548 · Cited by 170
Saldeen, J. (2000) · Endocrinology · doi:10.1210/en.141.6.2003 · Cited by 165
Dynamics of beta-cell mass in the growing rat pancreas. Estimation with a simple mathematical model
Finegood, D. T., Scaglia, L., & Bonner-Weir, S. (1995) · Diabetes · doi:10.2337/diabetes.44.3.249 · Cited by 164
The Canadian-European Randomized Control Trial Group (1988) · Diabetes · doi:10.2337/diab.37.11.1574 · Cited by 164
Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes.
Pietropaolo, M., Barinas-Mitchell, E., Pietropaolo, S. L., Kuller, L. H., & Trucco, M. (2000) · Diabetes · doi:10.2337/diabetes.49.1.32 · Cited by 159
Larsen, C. M., Wadt, K. A. W., Juhl, L. F., Andersen, H. U., Karlsen, A. E., Su, M. S.-S., Seedorf, K., Shapiro, L., Dinarello, C. A., & Mandrup-Poulsen, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.24.15294 · Cited by 155
Self-citationWatts, G. F., Mandalia, S., Brunt, J. N. H., Slavin, B. M., COLTART, D. J., & Lewis, B. (1993) · Metabolism · doi:10.1016/0026-0495(93)90199-x · Cited by 154
Chen, M. C., Proost, P., Gysemans, C. A., Mathieu, C., & Eizirik, D. L. (2001) · Diabetologia · doi:10.1007/s001250051622 · Cited by 154
Giannoukakis, N., Rudert, W. A., Ghivizzani, S. C., Gambotto, A. A., Ricordi, C., Trucco, M., & Robbins, P. D. (1999) · Diabetes · doi:10.2337/diabetes.48.9.1730 · Cited by 154
Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings
Marette, A. (2002) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200207000-00005 · Cited by 149
Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance
Bastard, J.-P., Pi�roni, L., & Hainque, B. (2000) · Diabetes/Metabolism Research and Reviews · doi:10.1002/1520-7560(200005/06)16:3<192::aid-dmrr114>3.0.co;2-g · Cited by 148
Karlsen, A. E., Rønn, S. G., Lindberg, K., Johannesen, J., Galsgaard, E. D., Pociot, F., Nielsen, J. H., Mandrup-Poulsen, T., Nerup, J., & Billestrup, N. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211445998 · Cited by 147
Self-citationLoweth, A. C., Williams, G. T., James, R. F., Scarpello, J. H., & Morgan, N. G. (1998) · Diabetes · doi:10.2337/diabetes.47.5.727 · Cited by 141
Tanabe, K., Okuya, S., Tanizawa, Y., Matsutani, A., & Oka, Y. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7894 · Cited by 140
Dandona, P., & Aljada, A. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02556-0 · Cited by 137
Maedler, K., Fontana, A., Ris, F., Sergeev, P., Toso, C., Oberholzer, J., Lehmann, R., Bachmann, F., Tasinato, A., Spinas, G. A., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122686299 · Cited by 136
Self-citationZhou, Y. P., Teng, D., Dralyuk, F., Ostrega, D., Roe, M. W., Philipson, L., & Polonsky, K. S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1245 · Cited by 130
Welsh, N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.14.8307 · Cited by 125
Tuomi, T., Groop, L., Zimmet, P., et al. (1993) · Diabetes · doi:10.2337/diabetes.42.2.359 · Cited by 123
IB1 Reduces Cytokine-induced Apoptosis of Insulin-secreting Cells
Bonny, C., Oberson, A., Steinmann, M., Schorderet, D. F., Nicod, P., & Waeber, G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908297199 · Cited by 122
Suarez‐Pinzon, W. L., Sorensen, O., Bleackley, R. C., Elliott, J. F., Rajotte, R. V., & Rabinovitch, A. (1999) · Diabetes · doi:10.2337/diabetes.48.1.21 · Cited by 121
Esch, T., & Stefano, G. B. (2002) · PubMed · Cited by 118
Spinas, G. A., Mandrup-Poulsen, T., Mølvig, J., Bæk, L., Bendtzen, K., Dinarello, C. A., & Nerup, J. (1986) · Acta Endocrinologica · doi:10.1530/acta.0.1130551 · Cited by 110
Self-citationRabinovitch, A., Suarez‐Pinzon, W. L., Sooy, K., Strynadka, K., & Christakos, S. (2001) · Endocrinology · doi:10.1210/endo.142.8.8334 · Cited by 109
Carpenter, L., Cordery, D., & Biden, T. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010036200 · Cited by 108
Flodström‐Tullberg, M., Welsh, N., & Eizirik, D. L. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00337-7 · Cited by 108
Nomikos, I. N., Prowse, S. J., Carotenuto, P., & Lafferty, K. J. (1986) · Diabetes · doi:10.2337/diab.35.11.1302 · Cited by 108
Gilligan, M., Welsh, G. I., Flynn, A., Bujalska, I., Diggle, T. A., Denton, R. M., Proud, C. G., & Docherty, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.2121 · Cited by 90
Insulin deficiency and insulin resistance in the pathogenesis of NIDDM: is a divorce possible?
Cerasi, E. (1995) · Diabetologia · doi:10.1007/bf00400591 · Cited by 88
Pavlović, D., Andersen, N. A., Mandrup-Poulsen, T. R., & Eizirik, D. L. (2000) · PubMed · Cited by 84
Self-citationAntibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus
Rowley, M. J., Mackay, I. R., Chen, Q. Y., et al. (1992) · Diabetes · doi:10.2337/diabetes.41.4.548 · Cited by 83
Flodström‐Tullberg, M., & Eizirik, D. L. (1997) · Endocrinology · doi:10.1210/endo.138.7.5286 · Cited by 80
Prevention of fat-induced insulin resistance by salicylate
Kim, J. K., Kim, Y. J., Fillmore, J. J., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200111559 · Cited by 80
Pukel, C., Baquerizo, H., & Rabinovitch, A. (1988) · Diabetes · doi:10.2337/diabetes.37.1.133 · Cited by 79
A Low Voltage-Activated Ca2+ Current Mediates Cytokine-Induced Pancreatic -Cell Death
Wang, L., Bhattacharjee, A., Zuo, Z., Hu, F., Honkanen, R. E., Berggren, P., & Li, M. (1999) · Endocrinology · doi:10.1210/endo.140.3.6556 · Cited by 78
Byrne, M. M., Sturis, J., Menzel, S., et al. (1996) · Diabetes · doi:10.2337/diabetes.45.11.1503 · Cited by 78
Stassi, G., Todaro, M., Richiusa, P., Giordano, M., Mattina, A., Sbriglia, M. S., Monte, A. I. L., Buscemi, G., Galluzzo, A., & Giordano, C. (1995) · PubMed · Cited by 76
Leptin Increases the Viability of Isolated Rat Pancreatic Islets by Suppressing Apoptosis
Okuya, S., Tanabe, K., Tanizawa, Y., & Oka, Y. (2001) · Endocrinology · doi:10.1210/endo.142.11.8494 · Cited by 73
Islam, M. S., Sjöholm, Å., & Emilsson, V. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801370 · Cited by 71
Perspective: The Search for Genes for Type 2 Diabetes in the Post-Genome Era
Elbein, S. C. (2002) · Endocrinology · doi:10.1210/endo.143.6.8831 · Cited by 70
Beta-cell maturation leads to in vitro sensitivity to cytotoxins.
Nielsen, K., Karlsen, A. E., Deckert, M., Madsen, O. D., Serup, P., Mandrup-Poulsen, T. R., & Nerup, J. (1999) · Diabetes · doi:10.2337/diabetes.48.12.2324 · Cited by 67
Self-citationBlood glycoprotein levels in diabetes mellitus
Jónsson, Á., & Wales, J. K. (1976) · Diabetologia · doi:10.1007/bf00422091 · Cited by 66
Pancreatic β-Cell Damage Mediated by β-Cell Production of Interleukin-1
Heitmeier, M. R., Arnush, M., Scarim, A. L., & Corbett, J. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009159200 · Cited by 64
Karlsen, A. E., Pavlović, D., Nielsen, K., Jensen, J. N., Andersen, H. U., Pociot, F., Mandrup-Poulsen, T. R., Eizirik, D. L., & Nerup, J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.2.6366 · Cited by 61
Self-citationThe role of interleukin-1 in the pathogenesis of IDDM
Mandrup-Poulsen, T. R. (1996) · Diabetologia · doi:10.1007/s001250050548 · Cited by 60
Self-citationWeringer, E. J., & Like, A. A. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.4.2383 · Cited by 59
Carpenter, L., Cordery, D. V., & Biden, T. J. (2002) · Diabetes · doi:10.2337/diabetes.51.2.317 · Cited by 59
Arterial Inflammation and Atherosclerosis
Ludewig, B. (2002) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00166-9 · Cited by 57
Viruses and Other Perinatal Exposures as Initiating Events for β-cell Destruction
Dahlquist, G. G. (1997) · Annals of Medicine · doi:10.3109/07853899708999371 · Cited by 56
Insulin Resistance Is Not Necessarily an Essential Component of Type 2 Diabetes1
Gerich, J. E. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.6.6646 · Cited by 56
SERUM CONCENTRATION OF α2-MACROGLOBULIN, HAPTOGLOBIN AND α1-ANTITRYPSIN IN DIABETES MELLITUS
Ganrot, P. O., Gydell, K., & Ekelund, H. (1967) · Acta Endocrinologica · doi:10.1530/acta.0.0550537 · Cited by 56
No decrease of the beta-cell mass in type 2 diabetic patients.
Guiot, Y., Sempoux, C. L., Moulin, P., & Rahier, J. (2001) · Diabetes · doi:10.2337/diabetes.50.2007.s188 · Cited by 54
Is type 2 diabetes a chronic inflammatory/autoimmune disease?
Syed, M. A., Barinas‐Mitchell, E., Pietropaolo, S. L., Zhang, Y., Henderson, T., Kelley, D. E., Korytkowski, M. T., Donahue, R. P., Tracy, R. P., Trucco, M., et al. (2002) · PubMed · Cited by 51
Wadt, K. A., Larsen, C. M., Andersen, H. U., Nielsen, K., Karlsen, A. E., & Mandrup-Poulsen, T. (1998) · Diabetes · doi:10.2337/diabetes.47.10.1602 · Cited by 50
Self-citationIslet-specific T cell clones transfer diabetes to nonobese diabetic (NOD) F1 mice.
Peterson, J. D., Pike, B. L., MCDUFFIE, M. J., & HASKINS, K. M. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.6.2800 · Cited by 49
Interleukin-1β Stimulation of c-Jun NH2-Terminal Kinase Activity in Insulin-Secreting Cells
Major, C. D., & Wolf, B. A. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2721 · Cited by 47
Nomikos, I. N., Prowse, S. J., Carotenuto, P., et al. (1986) · Diabetes · doi:10.2337/diabetes.35.11.1302 · Cited by 45
Wang, L., Bhattacharjee, A., Fu, J., & Li, M. (1996) · Diabetes · doi:10.2337/diab.45.12.1678 · Cited by 44
Pickup, J. C., Chusney, G. D., & Mattock, M. B. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.00921.x · Cited by 44
Imidazoline compounds protect against interleukin 1beta-induced beta-cell apoptosis.
Zaitsev, S. V., Appelskog, I. B., Kapelioukh, I. L., Yang, S. N., Köhler, M., Efendic, S., & Berggren, P. O. (2001) · Diabetes · doi:10.2337/diabetes.50.2007.s70 · Cited by 43
Insulin Resistance Is Not Necessarily an Essential Component of Type 2 Diabetes
Gerich, J. E. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.6.2113 · Cited by 43
Andersen, N. A., Larsen, C. M., & Mandrup-Poulsen, T. R. (2000) · Diabetologia · doi:10.1007/s001250051544 · Cited by 41
Self-citationEizirik, D. L., Flodstr�m, M., Karlsen, A. E., et al. (1996) · Diabetologia · doi:10.1007/s001250050528 · Cited by 37
Activation of Nuclear Factor-κB by Depolarization and Ca2+ Influx in MIN6 Insulinoma Cells
Bernal‐Mizrachi, E., Wu, W., Shornick, M. D., & Permutt, M. A. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s484 · Cited by 34
Heitmeier, M. R., Scarim, A. L., & Corbett, J. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12531 · Cited by 31
Ebstein, W. (2002) · PubMed · Cited by 30
Shoelson, S. E. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0383-x · Cited by 30
Borg, L. A. H., & Eizirik, D. L. (1990) · Immunology Letters · doi:10.1016/0165-2478(90)90155-j · Cited by 29
Etiology and Pathogenesis of Insulin Dependent Diabetes Mellitus
Skyler, J. S., & Rabinovitch, A. (1987) · Pediatric Annals · doi:10.3928/0090-4481-19870901-06 · Cited by 15
Shoelson, S. E. (2002) · Cited by 15
Wang, L., Bhattacharjee, A., Fu, J., et al. (1996) · Diabetes · doi:10.2337/diabetes.45.12.1678 · Cited by 10
Insulin deficiency and insulin resistance in the pathogenesis of NIDDM: is a divorce possible?
Cerasi, E. (1995) · Diabetologia · doi:10.1007/s001250050383 · Cited by 5
Aetiology and Pathogenesis of Insulin-Dependent Diabetes mellitus
Pociot, F., & Mandrup-Poulsen, T. R. (2015) · Frontiers of hormone research · doi:10.1159/000425669 · Cited by 4
Self-citation
Cited by
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Self-citationn−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
Calder, P. C. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1505s · Cited by 2,525
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62154-6 · Cited by 1,743
Mechanisms of Pancreatic β-Cell Death in Type 1 and Type 2 Diabetes
Cnop, M., Welsh, N., Jonas, J.-C., Jörns, A., Lenzen, S., & Eizirik, D. L. (2005) · Diabetes · doi:10.2337/diabetes.54.suppl_2.s97 · Cited by 1,491
The NLRP3 Inflammasome: A Sensor for Metabolic Danger?
Schroder, K., Zhou, R., & Tschopp, J. (2010) · Science · doi:10.1126/science.1184003 · Cited by 1,134
Metadata
- Authors
- Donath, M. Y., St�rling, J., Maedler, K., & Mandrup-Poulsen, T.
- Affiliations
- University Hospital Zurich (CH)
- Steno Diabetes Centers (DK)
- Corresponding author
- Donath, Marc Y.
- Venue
- Journal of Molecular Medicine
- Published
- 2003-08-01
- Volume
- 81
- Issue
- 8
- Pages
- 455-470
- ISSN
- 0946-2716 (ISSN-L)
- 1432-1440
- OpenAlex
- W2112115574
- Cited by
- 422
- References
- 172
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 11 · 2023: 8 · 2022: 16 · 2021: 15 · 2020: 12 · 2019: 21 · 2018: 17 · 2017: 17 · 2016: 21 · 2015: 24 · 2014: 23 · 2013: 24 · 2012: 28
- FWCI
- 17.90
- Type
- journal article
- Language
- en
- Open access
- green
- www.zora.uzh.ch
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Journal of Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- beta-cell death, beta-cell apoptosis, inflammatory mediators, type 1 diabetes, type 2 diabetes, insulitis, innate immune activation, adipokines, saturated fatty acids, insulin deficiency, anti-inflammatory therapy
- MeSH terms
- Animals, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Glucose, Humans, Immunity, Active, Immunity, Innate, Insulin Resistance, Islets of Langerhans, Autoimmunity, Cytokines, Apoptosis, Adipocytes, Inflammation Mediators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.